Institut Pasteur Korea

EN Texte en anglais Pas encore d'article dans ta langue : extrait en anglais.

Institut Pasteur Korea is an infectious disease-focused research institute located in Gyeonggi Province, Rep. of Korea. Its mission is to identify novel molecular targets and discover small molecules by utilizing its proprietary platforms to diagnose, treat and address serious unmet global public health needs. It was inaugurated as a nonprofit private research institute on 12 April 2004 as a collaboration between the Institut Pasteur in Paris and Korea Institute of Science and Technology (KIST) in Seoul and it is supported by the Korean government through the Ministry of Science and ICT (former Ministry of Science and Technology) and Gyeonggi Province. Institut Pasteur Korea has been a key driver of early drug discovery among the 33 members of the Institut Pasteur International Network located in 25 countries on 5 continents, including China, Cambodia, Laos, Vietnam and Korea within Asia. Institut Pasteur Korea is also focused on discovery biology to study and understand TB and on the development of new and more effective ways to diagnose and treat the disease. Institut Pasteur Korea also tackles COVID-19, Antimicrobial resistance, HCV, HBV, influenza, leishmaniasis, dengue fever and cancer. The Institute is housed in a purpose-built facility in the city of Pangyo in Gyeonggi Province, 20 km south of Seoul.